Molecular Pathways and Related Target Therapies in Liver Carcinoma

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|32|3279-3287

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.32, 2007-01, pp. : 3279-3287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Target Therapies in Pancreatic Carcinoma

By  

Current Medicinal Chemistry, Vol. 21, Iss. 8, 2014-03 ,pp. : 948-965

Bentham Science Publishers

Access to resources Recommend Favorite

Liver-Directed Therapies for Hepatocellular Carcinoma

By Arciero Cletus A.   Sigurdson Elin R.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 8, 2006-09 ,pp. : 768-774

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Apoptotic Signaling Pathways as a Target for the Treatment of Liver Diseases

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 14, 2008-12 ,pp. : 1485-1493

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular and Cellular Pathways as Treatment Targets for Biologic Therapies in Systemic Sclerosis

By  

Current Medicinal Chemistry, Vol. 22, Iss. 16, 2015-05 ,pp. : 1943-1955

Bentham Science Publishers

Access to resources Recommend Favorite

Killer Consequence of Liver Disease: Market Demands New Therapies for Hepatocellular Carcinoma

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 3, Iss. 2, 2005-01 ,pp. : 10-13

Adis International

Access to resources Recommend Favorite